Will 'Bristol-Myers' Exclude Tort Actions From—or Draw Them to—Pa.?
The U.S. Supreme Court's recent game-changing decision in Bristol-Myers Squibb v. Superior Court of California is widely seen as the beginning of the end for mass torts in several venues that have historically attracted large-scale litigation, including California and Missouri. But, for Pennsylvania, the ruling is expected to be much more of a mixed bag, and, according to some, could instead lead to an uptick in suit against certain defendants.
This premium content is reserved for The Legal Intelligencer subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now